S 3334 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To prohibit reductions in the workforce at the Drug Enforcement Administration, and for other purposes.
Summary
This bill prohibits the Drug Enforcement Administration from reducing its laboratory workforce through hiring freezes or workforce reductions due to spending cuts, budget reprogramming, or the probationary status of employees. The laboratory workforce includes forensic chemists, fingerprint specialists, digital forensic examiners, and other positions at DEA forensic laboratories, as well as positions being relocated to new forensic laboratories under construction. The bill does not restrict the Attorney General's authority to remove employees for misconduct or poor performance.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Sen. Shaheen, Jeanne [D-NH] (D-NH)
1 cosponsor
- Sen. Crapo, Mike [R-ID] (R-ID)
Actions (2)
- Dec 3, 2025 Read twice and referred to the Committee on the Judiciary. · senate
- Dec 3, 2025 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
December 3, 2025
Mrs. Shaheen (for herself and Mr. Crapo) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
A BILL
To prohibit reductions in the workforce at the Drug Enforcement Administration, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Laboratory Analysts and Biometric Personnel Act of 2025” or the “LAB Personnel Act of 2025”.
SEC. 2. DEFINITION.
In this Act, the term “laboratory workforce at the Drug Enforcement Administration” means—
(1) positions in the Drug Enforcement Administration at forensic laboratories of the Drug Enforcement Administration, including—
(A) forensic chemists;
(B) fingerprint specialists;
(C) digital forensic examiners; and
(D) any other positions in the Drug Enforcement Administration at such forensic laboratories; and
(2) other positions in the Drug Enforcement Administration at locations other than such a forensic laboratory that will be relocated to such a forensic laboratory that, as of the date of the enactment of this Act, is being constructed or otherwise finalized.
SEC. 3. PROHIBITION ON REDUCING THE LABORATORY WORKFORCE AT THE DRUG ENFORCEMENT AGENCY.
(a) In General.—The laboratory workforce at the Drug Enforcement Administration shall be exempt from any hiring freezes or workforce reductions related to spending cuts, reprogramming of funds, or the probationary status of employees.
(b) Rule of Construction.—Nothing in this section may be construed to restrict the authority of the Attorney General to manage the workforce of the Department of Justice under existing procedures in cases of misconduct or poor performance. <all>
Comments